EPISODE · Apr 12, 2021 · 11 MIN
What do you need to remember when facing CAR T-cell toxicities?
from Multiple Myeloma Hub
During the 3rd European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Professor Philip McCarthy, Roswell Park Comprehensive Cancer Center, Buffalo, US. We asked, What do you need to remember when facing CAR T-cell toxicities? In this podcast, McCarthy discusses the two main chimeric antigen receptor (CAR) T-cell toxicities: cytokine release syndrome (CRS), and immune effector cell-associated neurotoxicity syndrome (ICANS). Initially, McCarthy lists what to look out for in terms of symptoms in this highly practical podcast episode. He then describes the timeline for the appearance of these adverse advents and the current treatment strategies that are being used. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
During the 3rd European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Professor Philip McCarthy, Roswell Park Comprehensive Cancer Center, Buffalo, US. We asked, What do you need to remember when facing CAR T-cell toxicities? In this podcast, McCarthy discusses the two main chimeric antigen receptor (CAR) T-cell toxicities: cytokine release syndrome (CRS), and immune effector cell-associated neurotoxicity syndrome (ICANS). Initially, McCarthy lists what to look out for in terms of symptoms in this highly practical podcast episode. He then describes the timeline for the appearance of these adverse advents and the current treatment strategies that are being used. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
What do you need to remember when facing CAR T-cell toxicities?
No transcript for this episode yet
Similar Episodes
Apr 6, 2026 ·25m
Mar 30, 2026 ·27m